Stockholders' Equity - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Apr. 23, 2026 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
| Total stock-based compensation expenses | $ 17,492 | $ 19,515 | $ 34,802 | $ 39,517 | |
| Share repurchase, authorized amount | $ 100,000 | ||||
| Stock repurchased and retired (in shares) | 884,575 | ||||
| Stock repurchased and retired | $ 15,000 | ||||
| Stock repurchase program, remaining authorized, amount | $ 85,000 | $ 85,000 | |||
| MANTL | |||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
| Total stock-based compensation expenses | $ 3,900 | ||||
| X | ||||||||||
- Definition Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares that have been repurchased and retired during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|